Asclera

Active Ingredient(s): Polidocanol
FDA Approved: * March 30, 2010
Pharm Company: * CHEMISCH FBRK KRSSLR
Category: Blood Vessels

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Asclera Overview

Polidocanol is a local anaesthetic and antipruritic component of ointments and bath additives. It relieves itching caused by eczema and dry skin.[1] It is formed by the ethoxylation of dodecanol. Sclerotherapy Polidocanol is also used as a sclerosant, an irritant injected to treat varicose veins, under the trade names Asclera, Aethoxysklerol[2] and Varithena.[3] Polidocanol causes fibrosis inside varicose veins, occluding the lumen of the ve...

Read more Asclera Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Polidocanol

Recent Asclera Forums:

Possible Dosages for this and Related Drugs:

NDC Database Records for Asclera: (2 results)

Sorted by National Drug Code

• 46783-121 Asclera .005 g/ml Intravenous Injection, Solution by Merz Aesthetics, Inc.
• 46783-221 Asclera .01 g/ml Intravenous Injection, Solution by Merz Aesthetics, Inc.

Other drugs which contain Polidocanol or a similar ingredient: (2 results)

• POLIDOCANOL 1 discussion
• VARITHENA Polidocanol

Related Asclera Topics: